Infectious Disease

Latest News


Advancing UTI Treatment: Highlights from IDWeek 2024

Discover groundbreaking research on urinary tract infections, including findings from the EAGLE-2 and EAGLE-3 trials. Learn how gepotidacin, a first-in-class oral therapy, addresses antimicrobial resistance and unmet needs in UTI management.

Advancing UTI Treatment: Highlights from IDWeek 2024

The Untold Burden of Uncomplicated UTIs: Addressing Recurrence and Treatment Gaps

Learn about uncomplicated urinary tract infection (UTI) management updates, growing resistance issues, prevention strategies, antimicrobial stewardship, and the socioeconomic impact of treatment failures across diverse patient populations.

The Untold Burden of Uncomplicated UTIs: Addressing Recurrence and Treatment Gaps

CME Content


Peter Hotez, MD, PhD, FASTMH, Baylor College of Medicine

Peter Hotez, MD, PhD, FASTMH, professor of pediatrics and molecular virology and dean, National School of Tropical Medicine, Baylor College of Medicine, and codirector, Texas Children’s Hospital Center for Vaccine Development, addresses the approval of the Pfizer/BioNTech COVID-19 vaccine for children aged 5 to 11 and emphasized its benefits far outweigh the rare possibility of myocarditis.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo